Vicore Pharma Holding AB (publ) (VCRE) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Vicore Pharma Holding AB (publ) (VCRE) closed at USD 9.08 on 2026-10-14, a change of -44.1 % over the past year, with a market capitalization of USD 256.01M.

Vicore Pharma Holding AB (publ) recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Vicore Pharma Holding AB (publ) key figures

Previous close

USD 9.08 (2026-10-14)

1-year change

-44.1 %

Market cap

USD 256.01M

Enterprise value

n/a

P/E ratio (trailing)

-4.46

P/E ratio (forward)

n/a

EPS (trailing)

-2.04

EPS (forward)

n/a

PEG ratio

n/a

Price to book

n/a

Revenue growth

26.7 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.14

Employees

46

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Vicore Pharma Holding AB (publ)

Vicore Pharma Holding AB (publ), a clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden. The company develops Buloxibutid (C21), an orally available small molecule angiotensin II type 2 receptor agonist (ATRAG) that is in Phase II clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF), as well as in Phase I clinical trial for treating pulmonary hypertension. It also developing Almee, an investigational medical device in clinical development that has completed Phase III clinical stage to address the psychological impact of living with pulmonary fibrosis. It has a cooperation and development agreement with Emeriti Bio AB and HaLaCore Pharma AB to develop new follow-on molecules based on C21 and other drug substances targeting the AT2 receptor, as well as a collaboration and development agreement with Alex Therapeutics AB to develop a digital app in interstitial lung diseases, such as IPF. The company was formerly known as Mintage Scientific AB. Vicore Pharma Holding AB (publ) was founded in 2000 and is headquartered in Stockholm, Sweden.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Vicore Pharma Holding AB (publ) and compare it with other stocks.